Individual.com logo
Welcome   (I'm not )
Select a date:

My Topics
Click here to add topics
Table bottom

My Companies
Click here to add companies
Table bottom

Newsdesks
Business
Finance
Internet
Computing
Environmental
Energy
Healthcare
Industry News, A-Z
Sports
Telecom
Transportation
Table bottom

Search
Google News
Table bottom

My Settings
Topics
Companies
Personal Info
Preferences
Forgot Password?
Log out
Table bottom

Top Topics
No top stories
Table bottom

Top Topics
Alternative Energy
Financial Services & Investing
Economic Indicators
Labor
Commodities & Futures
International and US Foreign Trade
Obesity, Weight Control & Nutrition
Aerospace & Defense
Crime & Law Enforcement
Hospital Industry
Table bottom

Infectious Disease
--Medical Japan is the country's largest trade show focusing on products, services and technologies for healthcare. Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies...
BusinessWire, 10:23am ET



Iterum Therapeutics Limited, a clinical-stage pharmaceutical company developing anti-infectives for patients with infectious diseases and other acute illnesses, today announced the appointment of Jeff Schaffnit as Chief Commercial Officer....
PR Newswire, 10:14am ET

Industry Veteran To Lead Commercialization of Potential New Oral and IV Antibiotic DUBLIN and CHICAGO, Feb. 20, 2018 /PRNewswire/ -- Iterum Therapeutics Limited, a clinical-stage pharmaceutical company developing anti-infectives for...
PR Newswire Europe, 10:13am ET

The Karius test for infectious diseases detects microbial cell-free DNA (cfDNA) in plasma from more than a thousand pathogens from a single blood draw in one day using NGS, including bacteria, DNA viruses, fungi and protozoa. The test enables...
PRWeb, 9:33am ET

Moderna Therapeutics, a clinical stage biotechnology company that is pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for high unmet medical needs in patients,...
BusinessWire, 9:33am ET

Jiang Chongyang, 79, thinks the Chinese Lunar New Year holiday is the worst time of the year. Jiang has spent nearly 60 years living in an isolated leprosy prevention and treatment center in east China's Jiangxi Province. At the...
Xinhua, 9:28am ET

Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma" or the "Company") today announced that it will release financial results for the period ended December 31, 2017 after market close on Tuesday, February 27, 2018....
PR Newswire, 8:44am ET

Teladoc, Inc. (NYSE:TDOC), the world's largest and most trusted provider of virtual care delivery services, announced today that amid the most severe flu outbreak in a decade, the company has provided a record number of visits as telehealth...
GlobeNewswire, 8:43am ET

--- 13 patients with sickle cell disease transplanted with NiCord and engrafted at median seven days - Gamida Cell, a leading cellular and immune therapeutics company, today announced two presentations from its NiCord...
BusinessWire, 8:08am ET

Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that the United States Patent and Trademark Office (USPTO) issued U.S. Patent Number 9,895,385...
GlobeNewswire, 8:08am ET

BERKELEY HEIGHTS, NJ / ACCESSWIRE / February 20, 2018 / CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and...
ACCESSWIRE, 7:38am ET

Global Strategic Business Report" [https://www.researchandmarkets.com/research/s4kwsz/global?w=5] report has been added to ResearchAndMarkets.com's offering. http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg...
PR Newswire Europe, 7:08am ET

The "Nanotechnology - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. http://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg The report provides separate comprehensive...
PR Newswire, 7:08am ET

Melinta Therapeutics, Inc. (NASDAQ:MLNT), a commercial-stage company developing and commercializing novel antibiotics to treat serious bacterial infections, today announced that Eurofarma Laboratorios has submitted a marketing authorization...
GlobeNewswire, 7:08am ET

Proceeds to be Used to Commercialize HEPLISAV-B(TM) [Hepatitis B Vaccine (Recombinant), Adjuvanted] in United States and Advance Company's Immuno-Oncology Product Candidates Company Deploying HEPLISAV-B Field Sales Team Dynavax...
GlobeNewswire, 6:38am ET

Vical Incorporated (Nasdaq:VICL) announced today the initiation of a Phase 2 trial of the Company's VL-2397 novel antifungal compound. The multicenter, open label randomized clinical study, will compare the efficacy and safety of VL-2397 to...
GlobeNewswire, 6:08am ET

CytoDyn Inc. (OTC.QB:CYDY) reports the successful achievement of the primary endpoint in its CD02 Phase 2b/3 pivotal clinical trial with PRO 140 in combination with existing antiretroviral therapy (ART) in patients failing their current HIV...
GlobeNewswire, 6:08am ET

United States biotechnology company, RPS Diagnostics (RPS(R)), and Australian medical device company, Atomo Diagnostics, announced today that they have entered into a commercial and development partnership to create next generation FebriDx(R)...
PRWeb, 5:08am ET

Europe saw a 400-percent increase in measles cases in 2017 compared to the previous year, affecting more than 21,000 people and causing 35 deaths, the World Health Organization (WHO)'s regional office for Europe said in a press release Monday....
Xinhua, 2:58am ET

The World Health Organization (WHO) urged Tuesday for a further scale up of health services for nearly 1.3 million people in Cox's Bazar, Bangladesh as vulnerable populations remain at risk of disease and are in need of critical services for...
Xinhua, 2:38pm ET

1-20 of 225
Next 20 >>


Tell a Friend About Us

Home Help My Settings Privacy Policy Terms of Service Advertising About Us Contact Us Logout

Copyright 1995-, Individual.com. No redistribution allowed.